
A Phase II Trial of Temsirolimus in Men With Castration-Resistant Metastatic Prostate Cancer
Keywords: پادگن مخصوص پروستات; Castration-resistant; Circulating tumor cells; Epithelial-mesenchymal transition; Metastatic prostate cancer; mTOR; N-cadherin; Prostate-specific antigen; Temsirolimus